Search

EHA Kick-off Grants

This call is now closed.  

Kick-off Grant 

The EHA Kick-off Grant is a 1-year grant intended to support basic and translational early career researchers in hematology. The grant wants to kick-off novel concepts and ideas.

Read more

Scam alert

SCAM ALERT

We have been alerted of fraudulent emails sent to our members, faculty and partners. Be aware of ‘scam’ emails asking you to confirm your travel dates and to receive an invoice afterwards. This is a spam.

Read more

EHA-ISHBT Hematology Tutorial 2020

The 4th EHA-ISHBT Hematology Tutorial on Hematological Disorders was held on February 28 and 29 in Chandigarh, India, and chaired by Prof John Gribben, Prof Neelam Varma and Prof Pankaj Malhotra.

Read more

Application forms

EHA Ranking 2024 deadline is closed. Interested in becoming an EHA sponsor? Below you will find all the application forms for all the available EHA Sponsor Programs.

Read more

Compliance and reports

EHA is a non-governmental and not-for-profit membership organization that is guided by its mission to promote excellence in patient care, research and education in hematology.

Read more

EHA collaborates with THD to provide critical aid to hematologists

The Hague (Netherlands), June 23, 2023. The European Hematology Association (EHA) is proud to announce its partnership with the Türk Hematoloji Derneği (THD) in a joint effort to support hematologists working in earthquake-affected areas in Türkiye and Syria.

Read more

Mentoring peer-peer networks – a recipe for success

Isabel Peset1 & Alba Maiques-Diaz2

1 Senior Scientist, Microscopy, Medicines Discovery Catapult, Manchester, UK;
2 Postdoctoral scientist, Biomedical Epigenomics group, IDIBAPS, Barcelona, Spain; YoungEHA committee member.

Read more

Press Release "Crucial Directives must be revised to protect patients' interests and improve access to treatment"

This was a key message of a two-day conference, “Haematology and the next European decade”, hosted by the European Parliament and attended by doctors, researchers, parliamentarians, patients’ organisations and Commission officials.

Read more